Opioid addiction occupies a contested but richly documented position within the depth-psychology and addiction-studies corpus represented in this library. The passages assembled here resist any single theoretical settlement. Bruce Alexander’s dislocation theory relocates the causal center of opioid addiction away from pharmacological inevitability—challenging the ‘demon-drug myth’ by arguing that withdrawal symptoms are neither necessary nor sufficient to produce addiction, and that heroin’s extraordinary efficacy in relieving emotional anguish makes it peculiarly attractive to the severely dislocated. Gabor Maté approaches opioid use through attachment neuroscience and developmental trauma, situating compulsive opioid use within broader dysregulations of the brain’s endogenous opioid and reward systems. The biomedical literature represented by Avery, Timko, Nabipour, and Stewart foregrounds epidemiology, medication-assisted treatment (methadone, buprenorphine, naltrexone), interoceptive neurology, and public-health frameworks. Avery’s account of the therapeutic community model adds a sociological and rehabilitative dimension, placing opioid use disorder within carceral systems, community reintegration, and identity transformation. A persistent tension runs throughout: whether opioid addiction is primarily a disease of neurochemistry, a symptom of social dislocation, or a failure of relational and nutritional sustenance—with major clinical and ethical consequences for how treatment and recovery are conceived.
it has become absolutely clear that withdrawal symptoms are neither necessary to cause opioid addiction nor sufficient to maintain it once a person has become addicted. The cause of opioid addiction lies elsewhere.
Alexander argues that the pharmacological mechanism of withdrawal cannot explain opioid addiction, demanding a causal explanation grounded in psychosocial dislocation rather than neurochemistry.
, The Globalisation of Addiction: A Study in Poverty of the Spirit, 2008thesis
Heroin, like the other opioid agonists, is extraordinarily effective in relieving both physical pain and emotional anguish. The relief it provides is experienced as intensely pleasurable. Anguish is the dominating emotion in people suffering from dislocation.
Alexander’s dislocation theory holds that heroin’s addictive grip derives from its power to assuage the emotional anguish endemic to social dislocation, not from any intrinsic chemical compulsion.
, The Globalisation of Addiction: A Study in Poverty of the Spirit, 2008thesis
opioid replacement therapy reduces relapse compared to counseling-based treatment alone and is generally considered the gold standard for the treatment of opioid use disorder.
Avery presents opioid replacement therapy with long-acting agonists as the evidence-based gold standard for treating opioid use disorder, superior to counseling alone.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019thesis
The United States’ long history of overreliance on pharmacological approaches to pain management, as well as an underestimation about the addictive potential of opioid analgesics, opened the floodgates to the opioid epidemic.
Avery locates the structural origins of the opioid epidemic in a culture of aggressive pharmaceutical pain management and systematic underestimation of addictive potential.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019thesis
heroin truly is a ‘drug of addiction’. All over the world, people who are drifting towards serious addiction are drawn to it, despite knowing its dangers.
While dismantling the demon-drug myth, Alexander concedes heroin’s genuine addictive pull, situating that pull within a theory of spreading spiritual impoverishment rather than pharmacological inevitability.
, The Globalisation of Addiction: A Study in Poverty of the Spirit, 2008supporting
Methadone maintenance has demonstrated marked reduction in mortality, decreased illicit substance use, decreased rates of HIV seroconversion, diminished co-occurring criminal activity/prosecution, and overall increased social engagement.
Avery documents the multidimensional public-health benefits of methadone maintenance, situating pharmacotherapy as central to reducing the harms associated with opioid addiction.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019supporting
A dependence on opiates such as heroin or prescription painkillers is one of the most devastating addictions found in the treatment community.
Nabipour frames opiate dependence as uniquely severe among addictions and surveys medication-assisted treatment options as the most effective clinical responses.
, Burden and Nutritional Deficiencies in Opiate Addiction- Systematic Review Article, 2014supporting
Opiate addiction is now becoming a worldwide problem as 13-22 million people are afflicted and Asia encompasses more than half of that.
Nabipour provides epidemiological scope for opiate addiction, establishing it as a global public health crisis with disproportionate concentration in Asia.
, Burden and Nutritional Deficiencies in Opiate Addiction- Systematic Review Article, 2014supporting
The addiction is devastating, because you’re not even clear anymore why you’re taking it.
Maté uses a clinical case narrative to illustrate how opioid addiction dissociates the user from conscious motivation, eroding the capacity for self-understanding.
, In the Realm of Hungry Ghosts: Close Encounters With Addiction, 2008supporting
opioid addiction drew little public attention as a stand alone health issue to be treated or prevented. Society’s response has largely been driven by the co
Avery traces the historical neglect of opioid addiction as an independent health issue, arguing that societal responses have been reactive rather than preventive.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019supporting
extended-release OxyContin became incredibly popular. This drug was aggressively marketed and promoted as a nonaddictive formulation of oxycodone.
Avery details how pharmaceutical marketing falsely framing OxyContin as non-addictive was a proximate driver of the prescription opioid epidemic.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019supporting
injection of purified morphine likely potentiated the addictive qualities as it allowed for rapid acting delivery, and cases of morphine dependence among the general public began to rise.
Avery traces the historical iatrogenesis of opioid addiction to the invention of the hypodermic needle and the wartime use of injectable morphine, which accelerated dependence.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019supporting
Blunted anterior insula activation during interoceptive perturbations has been associated with stimulant (cocaine and amphetamine) use disorder (SUD) and is related to risk for and prognosis of SUD.
Stewart investigates whether interoceptive neural alterations documented in stimulant use disorder also characterize opioid use disorder, linking neurobiological markers to addiction prognosis.
, Interoceptive attention in opioid and stimulant use disorder, 2019supporting
Substitute prescribing is a favoured treatment for heroin addiction today, but it should not be valued at the expense of other treatments.
Addenbrooke cautions against over-reliance on substitute prescribing for heroin addiction, advocating for integration with psychotherapeutic approaches and warning of methadone mortality risks.
, Survivors of Addiction: Narratives of Recovery, 2011supporting
pharmaceutical companies organised extensive research projects to discover an opioid painkiller that was as effective as morphine or heroin but did not attract recreational and addictive users.
Alexander contextualizes the pharmaceutical industry’s failed search for a non-addictive opioid as emblematic of the intractability of opioid addiction to purely chemical solutions.
, The Globalisation of Addiction: A Study in Poverty of the Spirit, 2008supporting
the degree of impairment across these six dimensions—whether due to the severity of substance use, comorbid psychiatric disorders, socioeconomic instability, homelessness, and involvement in the legal system, among other comp
Avery delineates a multidimensional clinical framework for matching patients with opioid use disorder to appropriate treatment levels, highlighting the role of psychiatric comorbidity and social instability.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019supporting
OUD has been associated with decreased levels of blood glucose, thiamine, vitamin B6, folate, vitamin C, potassium, calcium, magnesium, zinc, selenium, and cholesterol.
Wiss documents the extensive micronutrient deficiencies associated with opioid use disorder, linking nutritional depletion to the physiological burden of addiction.
, The Role of Nutrition in Addiction Recovery: What We Know and What We Don’t, 2019supporting
Methadone is a pharmacological that reduces the opiate craving as well as lessens withdrawal symptoms and if it coupled with counseling, enables to reach tolerance threshold although prevents from drowsiness and euphoria.
Nabipour outlines the clinical pharmacology of methadone maintenance, emphasizing its craving-reduction mechanism and the necessity of coupling it with psychosocial counseling.
, Burden and Nutritional Deficiencies in Opiate Addiction- Systematic Review Article, 2014supporting
In 2010 OxyContin and other prescription opioids were reformulated to an abuse-deterrent formula, leading to the intended positive effects of decreased rates of OxyContin abuse and a relative leveling off of deaths related to prescription opioids by 2013.
Avery documents the partial efficacy of reformulation policy in curbing prescription opioid abuse, while contextualizing it within the broader transition toward heroin and synthetic opioids.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019aside
The frame ‘Yes, and’ structures our discussion of the therapeutic community (TC) model for opioid use disorder (OUD) as we place it within the larger system of care for individuals living with addiction.
Avery introduces the therapeutic community model as a complementary—not competing—modality within a comprehensive system of care for opioid use disorder.
, The Opioid Epidemic and the Therapeutic Community Model: An Essential Guide, 2019aside
this study focused on medication and behavioral therapy factors related to retention in MAT for opiate addiction, to the exclusion of other factors such as patient determinants.
Timko acknowledges methodological limitations in MAT retention research, noting that patient-level determinants of retention in opiate addiction treatment remain underexplored.
, Retention in medication-assisted treatment for opiate dependence: A systematic review, 2016aside